Prism adaptation treatment for upper-limb Complex Regional Pain Syndrome: a double-blind randomized controlled trial
View ORCID ProfileMonika Halicka, View ORCID ProfileAxel D. Vittersø, View ORCID ProfileHayley McCullough, View ORCID ProfileAndreas Goebel, Leila Heelas, View ORCID ProfileMichael J. Proulx, View ORCID ProfileJanet H. Bultitude
doi: https://doi.org/10.1101/2020.03.18.20038109
Monika Halicka
aCentre for Pain Research, University of Bath, Bath, United Kingdom
bDepartment of Psychology, University of Bath, Bath, United Kingdom
Axel D. Vittersø
aCentre for Pain Research, University of Bath, Bath, United Kingdom
bDepartment of Psychology, University of Bath, Bath, United Kingdom
cDepartment of Sport and Health Sciences, University of Exeter, Exeter, United Kingdom
Hayley McCullough
dPain Research Institute, Department of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
Andreas Goebel
dPain Research Institute, Department of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
eDepartment of Pain Medicine, Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
Leila Heelas
fOptimise Pain Rehabilitation Unit, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
Michael J. Proulx
bDepartment of Psychology, University of Bath, Bath, United Kingdom
gCentre for Real & Virtual Environments Augmentation Labs, Department of Computer Science, University of Bath, Bath, United Kingdom
Janet H. Bultitude
aCentre for Pain Research, University of Bath, Bath, United Kingdom
bDepartment of Psychology, University of Bath, Bath, United Kingdom
Article usage
Posted July 14, 2020.
Prism adaptation treatment for upper-limb Complex Regional Pain Syndrome: a double-blind randomized controlled trial
Monika Halicka, Axel D. Vittersø, Hayley McCullough, Andreas Goebel, Leila Heelas, Michael J. Proulx, Janet H. Bultitude
medRxiv 2020.03.18.20038109; doi: https://doi.org/10.1101/2020.03.18.20038109
Prism adaptation treatment for upper-limb Complex Regional Pain Syndrome: a double-blind randomized controlled trial
Monika Halicka, Axel D. Vittersø, Hayley McCullough, Andreas Goebel, Leila Heelas, Michael J. Proulx, Janet H. Bultitude
medRxiv 2020.03.18.20038109; doi: https://doi.org/10.1101/2020.03.18.20038109
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12337)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (866)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)